Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Coya Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get COYA alerts

About Fred Grossman

Fred Grossman is recorded as Board Member at Coya Therapeutics, Inc. (COYA) since January 1, 2023. The newest filing on record that lists Fred Grossman as Board Member at Coya Therapeutics, Inc. (COYA) is dated May 13, 2026. Coya Therapeutics, Inc. reported in an 8-K filed July 10, 2023 that Fred Grossman was appointed President and Chief Medical Officer, effective July 17, 2023. The proxy statement of Coya Therapeutics, Inc. reports total compensation of $1,457,433 for Fred Grossman in fiscal 2025, including a base salary of $498,160. Disclosed compensation is on record for 4 fiscal years. Fred Grossman has spoken on 1 investor event across 1 company, most recently for Coya Therapeutics, Inc. on October 20, 2026. Coya Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Coya Therapeutics, Inc. includes Arun Swaminathan (CEO and Board Member), Dr. Arun Swaminathan (CEO), Howard Berman (Chairman) and 7 others.

“On July 3, 2023, the Company appointed Dr. Fred Grossman President and Chief Medical Officer, effective July 17, 2023.”
Coya Therapeutics, Inc. Form 8-K, filed July 10, 2023 · Read the filing

Fred Grossman on recent calls

“We've heard that before, and we know that the inflammatory activity is quite high in ALS. And the cornerstone of this inflammation, we believe, are regulatory T cells.”
Board Member, Chardan Healthcare Conference – Right Target, Small Effect? Rethinking CNS ·

Affiliation history

Company network

Leadership on record at Coya Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Coya Therapeutics, Inc. (COYA) $498,160 $1,457,433
2024 Coya Therapeutics, Inc. (COYA) $479,000 $1,892,438
2023 Coya Therapeutics, Inc. (COYA) $227,000 $592,482
2022 Coya Therapeutics, Inc. (COYA) — —

Recent activity